Thanks to the hard work of those who founded this blog and for those who insisted on inviting me. I have only scorn for those who failed to do either of the above, particularly those who failed to do the later.
There was a commentary in today’s Wall Street Journal discussing improving transparency in our health care system by publicly releasing data contained in insurance claims which is required under the ACA. The title of the article is More Transparency, Better Health Care but it is behind a pay wall (although I managed to get the full text as part of a “free pass”).
The commentary is quiet short and superficial, but it had a few interesting highlights that may be worthy of additional thought and discussion:
Rates of preventable diseases, hospitalizations, complications and readmissions vary greatly among health-care providers.
This sort of addresses something NoVa raised at the PL a while ago (although not exactly the same) in that there are often large regional variations in treatment regimens that lead to disparate spending and outcomes. Some of this is understandable as population differences will impact treatment differences, but it seems to me that there should be fewer differences than presently exist. The question, of course, is how do decrease those differences. I wonder what role competition plays here. Competition between health care providers may decrease cooperation and sharing knowledge but should also spur innovation (although under the present system there is less incentive to prevent disease or prevent readmission).
Too often, unnecessary, redundant and needlessly expensive tests and treatments are prescribed.
Well, now we’re just stating the obvious in a very unhelpful way. The reasons these treatments are prescribed vary widely.
Controlling costs without compromising quality will require multiple scalpels rather than one blunt instrument. Public reporting of performances measure could provide those scalpels by allowing the public to compare doctors and hospitals based on cost and clinical results.
Now we get to the crux of the commentary and to an issue raised by other PL contributors. Would a more informed public make better decisions with their health care dollars? The authors answer in the affirmative, but fail to provide any real explanation as to how or how much. I think it would be hard to argue that making the data available is a bad thing (assuming the data is accurate) but I am skeptical that it would make too much of a difference. We often don’t have time to comparison shop and even if we are afforded the time to do so, would we take the time to do so and would the time we spend shopping really be time well spent? Perhaps more importantly, as long as we still have the same health insurance system, won’t people just choose the person with the best “stats” regardless of costs? This seem particularly true when we consider that most health care dollars are spent at the end of life and often those treatment decisions are made by spouses and children who are both emotionally invested and, with respect to children, not impacted financially (inheritance aside) by how much a given treatment decision costs.
I wish the article had been more informative, but I do think it is good starting point for a conversation.
Filed under: Uncategorized | 12 Comments »